Literature DB >> 3993450

Medical therapy of hypothalamic diseases.

K von Werder, O A Müller.   

Abstract

Hormonal disturbances caused by hypothalamic pathology can be treated effectively by target hormone replacement in the case of failure of glandotropic hormone secretion. Hyposomatotropism in children has to be substituted by parenteral administration of growth hormone. In addition gonadotropins respectively gonadotropin releasing factor have to be given in order to restore fertility in hypothalamic hypogonadism. Posterior pituitary failure can be adequately replaced by administration of analogues of antidiuretic hormone. Hypothalamic pathology causing hypersecretion of anterior pituitary hormones may also be accessable to medical treatment. This pertains particularly to hyperprolactinemia and precocious puberty. However, there is no medical therapy so far for hypothalamic disturbances leading to veterative dysfunction like disturbances of temperature regulation and control of thirst and polyphagia. In this situation symptomatic correction of the abnormality represents the only possibility to keep these patients alive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3993450     DOI: 10.1007/bf01406335

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  6 in total

1.  [Therapy of male hypogonadotropic hypogonadism by pulsatile administration of gonadotropin-releasing hormones].

Authors:  K von Werder; T Eversmann
Journal:  Dtsch Med Wochenschr       Date:  1984-03-16       Impact factor: 0.628

2.  Nonendocrine diseases and disorders of the hypothalamus.

Authors:  F Plum; R Van Uitert
Journal:  Res Publ Assoc Res Nerv Ment Dis       Date:  1978

3.  Long-term treatment of central precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. Effects on somatic growth and skeletal maturation.

Authors:  M J Mansfield; D E Beardsworth; J S Loughlin; J D Crawford; H H Bode; J Rivier; W Vale; D C Kushner; J F Crigler; W F Crowley
Journal:  N Engl J Med       Date:  1983-11-24       Impact factor: 91.245

4.  Effects of human pancreatic tumour growth hormone releasing factor on growth hormone and somatomedin C levels in patients with idiopathic growth hormone deficiency.

Authors:  J L Borges; R M Blizzard; M C Gelato; R Furlanetto; A D Rogol; W S Evans; M L Vance; D L Kaiser; R M MacLeod; G R Merriam; D L Loriaux; J Spiess; J Rivier; W Vale; M O Thorner
Journal:  Lancet       Date:  1983-07-16       Impact factor: 79.321

5.  Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone.

Authors:  A R Hoffman; W F Crowley
Journal:  N Engl J Med       Date:  1982-11-11       Impact factor: 91.245

Review 6.  [Pulsatile treatment with gonadotropin-releasing hormone (Gn-RH)].

Authors:  G Leyendecker; L Wildt
Journal:  Geburtshilfe Frauenheilkd       Date:  1982-09       Impact factor: 2.915

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.